Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Evolent Health, Inc. (NYSE: EVH)
EVH Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
13%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
63.40%
EVH Stock Analysis
EVH
PE Ratio:
EVH
PEG Ratio:
EVH
Forward EPS Growth (12 month):
160.40%
EVH
PS Ratio:
0.2
EVH
PSG Ratio:
EVH
Forward Revenue Growth (12 month):
19.10%
EVH Articles
No data was found